PMID- 26277996 OWN - NLM STAT- MEDLINE DCOM- 20160606 LR - 20220311 IS - 1421-9913 (Electronic) IS - 0014-3022 (Linking) VI - 74 IP - 1-2 DP - 2015 TI - Anti-NMDAR Encephalitis of 11 Cases in China - Detailed Clinical, Laboratory and Imagiological Description. PG - 73-8 LID - 10.1159/000435953 [doi] AB - BACKGROUND AND PURPOSE: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a synaptic autoimmune disorder in which the auto-antibodies target NMDARs were first reported in 2007. Now, anti-NMDAR encephalitis is a widely recognized disease in the world. Our purpose was to analyze the clinical characteristics of anti-NMDAR encephalitis patients in West China Hospital in China and report the prognosis of the patients after accepting immunotherapy. METHODS: Patients admitted to the West China Hospital who were diagnosed with anti-NMDAR encephalitis from 2013 to 2014 were retrospectively collected and their clinical features were analyzed. RESULTS: We ultimately included 11 anti-NMDAR encephalitis patients. The median age of the 11 patients was 25 years, 46% patients were females, 27% patients were 15-18 years, and 73% patients were over 18 years. One of them was diagnosed with teratoma after discharging from hospital. The application of immunotherapy produced favorable outcomes in 67% patients included in our study. CONCLUSIONS: Anti-NMDAR encephalitis should be suspected in patients who developed a rapid change in behavior or psychosis, seizures, dyskinesia, and hypoventilation. Anti-NMDAR encephalitis is a kind of fatal but treatable disease. Timely diagnosis and treatment may yield favorable prognosis. CI - (c) 2015 S. Karger AG, Basel. FAU - Liu, Junfeng AU - Liu J AD - Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. FAU - Wang, Deren AU - Wang D FAU - Xiong, Yao AU - Xiong Y FAU - Liu, Bian AU - Liu B FAU - Liu, Ming AU - Liu M LA - eng PT - Journal Article DEP - 20150808 PL - Switzerland TA - Eur Neurol JT - European neurology JID - 0150760 RN - 0 (Receptors, N-Methyl-D-Aspartate) SB - IM MH - Adolescent MH - Adult MH - Anti-N-Methyl-D-Aspartate Receptor Encephalitis/*diagnosis/immunology/therapy MH - China MH - Female MH - Humans MH - Male MH - Prognosis MH - Receptors, N-Methyl-D-Aspartate/immunology MH - Retrospective Studies MH - Young Adult EDAT- 2015/08/19 06:00 MHDA- 2016/06/09 06:00 CRDT- 2015/08/18 06:00 PHST- 2015/02/16 00:00 [received] PHST- 2015/06/14 00:00 [accepted] PHST- 2015/08/18 06:00 [entrez] PHST- 2015/08/19 06:00 [pubmed] PHST- 2016/06/09 06:00 [medline] AID - 000435953 [pii] AID - 10.1159/000435953 [doi] PST - ppublish SO - Eur Neurol. 2015;74(1-2):73-8. doi: 10.1159/000435953. Epub 2015 Aug 8.